"These drugs are very effective, but they're scary and they're chaotic and they're unpredictable," says Dillan DiNardo, highlighting the challenges faced by psychedelics despite their benefits.
Mindstate Design Labs believes that tweaking psychedelics could improve patient experiences and regulatory acceptance, especially after the FDA's recent refusal to approve MDMA for PTSD treatment.
Cosmo Feilding Mellen notes that traditional psychedelics come with 'too much baggage', suggesting that next-generation medications could mitigate risks while retaining therapeutic benefits.
Research indicates that psychedelics like MDMA and psilocybin enhance neuroplasticity, enabling beneficial mental health improvements by reshaping harmful thought patterns.
Collection
[
|
...
]